Dr. Carolin Barth Joins MiroBio as CEO to Lead Precision Immunology Company Focused on Checkpoint Agonist Antibodies
Former Novartis executive to lead emerging biotech with a novel precision approach to autoimmune disease, supported by recent senior appointmentsMiroBio...